Group items tagged

The National Pharmacy Association (NPA) has called on the NHS and the Department of Health to immediately publish the government-commissioned analysis of pharmacy underfunding and reveal the true scale of the crisis. Commissioned by NHS England, the long-awaited independent review is expected to "lay bare the perilous financial state" of community pharmacies, which is a vital part of the nation's health infrastructure. However, the NPA is concerned that the government may delay its release until after current funding consultations are concluded. The NPA argued that the public needs to understand the fragile nature of the pharmacy network before any new deal can be agreed. It has also warned health officials not to hide "the true scale of funding needed to reverse a decade of swingeing cuts", which has forced record numbers of pharmacy closures. NPA chair Nick Kaye said: "It would be a scandal to keep that evidence buried secret and leave MPs, pharmacies and the public in the dark." He acknowledged that the new government has inherited a crisis in pharmacy funding and emphasised that it will need to take "strong action" to maintain access to medicines.

The National Pharmacy Association (NPA) has raised the alarm that many community pharmacies are facing losses on NHS prescriptions due to the "broken" funding system. An analysis of prescription drug prices by the NPA revealed that pharmacies are being underpaid by the NHS by up to £75 a pack for common medicines, resulting in losses of thousands of pounds each month. The analysis report released today (16 October) shows the government reimburses £18.06 for a 56-tablet pack of Amantadine, a drug used to treat Parkinson's symptoms. However, the market price of the drug is £94.05 per pack, leading to a loss of £75.99 per 56-tablet pack for pharmacies-amounting to a shortfall of over £1 per tablet. In some instances, NHS funding covers only one-fifth of the cost that pharmacies have to pay for medicines, according to new figures from the NPA.

The UK has witnessed a nearly 50 percent increase in pharmacy closures this year compared to the same period in 2023, which was already considered the worst year in recent memory. A new analysis by the National Pharmacy Association (NPA) revealed that 177 pharmacies closed their doors between January and April 2024, compared to 116 in the same period last year. This is the equivalent of 10 local pharmacies shutting down every week. Analysis of NHS figures by the NPA showed that 403 pharmacies closed their doors last year, nearly five times higher than the number that closed in 2022. Since 2017, over 1,400 pharmacies have shut down across the UK. Rising costs and declining real terms funding have led to the fastest rate of closures in decades, said the NPA, highlighting that "real terms funding has decreased by 40 per cent over the last decade."

The Government has been forced to intervene formally 50 times in the past two years to authorise the use of alternative drugs because of serious medicine shortages hitting patients, new analysis by the National Pharmacy Association (NPA) has found today. 78 per cent of all Serious Shortage Protocols, produced by the Department of Health and Social Care (DHSC) due to medicine shortages, were issued in 2022/24 - more than three times the rate in the previous two years. The NPA, which represents independent community pharmacies in the UK, is warning that shortages are leading to pharmacists having to increasingly turn patients needing vital medication away. Analysis by the NPA of the NHS's Serious Shortage Protocols (SSPs) issued to pharmacies and other providers over the last five years has found that: The number of SSPs issued in the last two years is 3.5 times higher than in the previous two years.

The National Pharmacy Association (NPA) has disclosed alarming figures on pharmacy closure in England, attributing them to the impact of funding cuts. According to NPA analysis of NHS Business Services Authority (NHSBSA) data, 222 pharmacies permanently closed their doors in 2024, marking the second-highest annual closure rate on record. This equates to an average of four pharmacies closing each week. Nearly 90 per cent of council areas have seen at least one pharmacy shut permanently in just the last two years. NPA chair Nick Kaye voiced concern that pharmacies have been "pushed to breaking point" by 40 per cent real terms cuts to their budgets and the ones still open are left "hanging on by their fingertips" and could be forced to close without "an urgent increase in their funding." "It is patients that have lost out the most, with more people in isolated areas having to travel further for vital medication as well as access to medical advice convenient to them," he said.

Rural areas have been hit the hardest by a wave of pharmacy closures over the past two years, according to a new analysis by the National Pharmacy Association (NPA). The analysis published today revealed that nearly nine in ten council areas across England have suffered the loss of vital pharmacies and warned that many rural areas risk becoming "pharmacy deserts" if the current closure rates continue. Additionally, the NPA, which represents independent community pharmacies, warned that England faces a significant risk to the availability of essential medicines if "a decade of underfunding and closures" is not addressed. It is calling on the government to reverse the 40 per cent real-terms cuts to community pharmacy budgets over the past decade, which have led to the closure of over 1,500 pharmacies and forced many others to reduce their opening hours. NPA Chief Executive, Paul Rees said: "These shocking statistics show how a growing number of areas are at risk of becoming pharmacy deserts, with people in rural towns and villages having to travel longer and longer distances to get hold of the medication they need.

The UK is far behind comparable nations in spending on medicines and community pharmacies, according to a new analysis by the National Pharmacy Association (NPA). Published today, the report highlights that Britain ranks among the worst countries in the Organisation for Economic Co-operation and Development (OECD) for access to pharmacies, with fewer pharmacies per 100,000 people than countries like Bulgaria, Latvia, Romania, Portugal, Spain, Turkey, France, and many others. On average, a UK pharmacy serves around 5,700 patients, far more than those in France (3,238 patients) and the Republic of Ireland (2,500 patients), where an average pharmacy caters to less than half the number of patients served in the UK. All comparable countries manage fewer patients per pharmacy. The NPA analysis also found that the UK spends less per capita on medicines than nations such as Australia, Ireland, Japan, the US, Spain, Germany, and Italy. Germany spends twice as much as the UK, while the US spends nearly three times more.

The National Pharmacy Association (NPA) has revealed shocking figures showing that millions of patients across England have lost access to pharmacies due to widespread closures and reduced operating hours. According to NPA analysis of NHS data, around 1,250 pharmacies have permanently closed since 2017, and the majority of these closures have come in the last three years. Given that each pharmacy serves an average of 5,600 people, this decline in pharmacy numbers means that about 7 million people-equivalent to one in eight of England's population-have seen their local pharmacy shut down since 2017. Furthermore, NPA analysis found that pharmacies in England were open for 551,000 hours a week in 2024, down from 620,000 at the same time in 2022, a reduction of around 7 million hours in the last two years. Rural areas were particularly impacted, with Cambridgeshire, Wiltshire, Kent and Devon losing maximum hours of pharmacy care and time.

Many community pharmacies are under severe financial strain due to chronic underfunding and a mismatch between medicine costs and reimbursement rates. A report by the National Pharmacy Association (NPA) revealed that NHS underpays pharmacies by up to £75 a pack for common medicines, resulting in losses of thousands of pounds each month. The NPA analysis found that, in many instances, NHS funding covers only one-fifth of their purchase costs for medicines. Nemesh Patel, Managing Director of the Southdowns Pharmacy Group, said the current pharmacy funding contract is "completely broken and beyond farcical." Sharing their struggles, he tells Pharmacy Business: "Our teams are wasting hours and hours trying to just source medication for patients when they could be better using that time to clinically support our patients, and then when it comes to reimbursement, the drug tariff prices or concessionary prices are structured such that on hundreds of medications we dispense per month, we will be making a significant financial loss, each and every single time our pharmacies dispense that medication."